(Q36014866)

11 August 2017

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans (English)

1 reference

11 August 2017

1 reference

1 reference

19

Sarah C Gilbert

0 references

Teresa Lambe

4

Teresa Lambe

1 reference

11 August 2017

6

Alexandra J Spencer

1 reference

11 August 2017

Patrick J Lillie

1

0 references

Adrian V. S. Hill

18

Adrian V S Hill

1 reference

11 August 2017

Timothy J Powell

3

0 references

John Oxford

16

John Oxford

1 reference

11 August 2017

Robert Lambkin-Williams

14

Rob Lambkin Williams

1 reference

11 August 2017

13

Saul N Faust

1 reference

11 August 2017

11

Susanne H Sheehy

1 reference

11 August 2017

7

Matthew Hamill

1 reference

11 August 2017

5

Caitlin Mullarkey

1 reference

11 August 2017

2

Tamara K Berthoud

1 reference

11 August 2017

8

Yanchun Peng

1 reference

11 August 2017

9

Marie-Eve Blais

1 reference

11 August 2017

Christopher J A Duncan

10

1 reference

11 August 2017

Tom Havelock

12

1 reference

11 August 2017

Anthony Gilbert

15

1 reference

11 August 2017

Tao Dong

17

1 reference

11 August 2017

language of work or name

English

0 references

publication date

22 March 2012

1 reference

Clinical Infectious Diseases

11 August 2017

1 reference

11 August 2017

55

1 reference

11 August 2017

1

1 reference

11 August 2017

19-25

1 reference

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

The human cytotoxic T cell response to influenza A vaccination.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369564

Influenza vaccine market dynamics

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22441650

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIS327

1 reference

release_2m72ajzhq5ctnk4nux6tyksz64

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2m72ajzhq5ctnk4nux6tyksz64

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 August 2017

1 reference